Clobenztropine
Clobenztropine is a medication used primarily in the treatment of Parkinson's disease and extrapyramidal symptoms caused by other medications. It belongs to the class of drugs known as anticholinergics, which work by blocking the action of acetylcholine in the central nervous system.
Medical Uses[edit | edit source]
Clobenztropine is primarily prescribed for the management of Parkinson's disease, a neurodegenerative disorder characterized by tremors, rigidity, and bradykinesia. It is also used to treat extrapyramidal symptoms (EPS), which are drug-induced movement disorders that can occur with the use of antipsychotic medications.
Mechanism of Action[edit | edit source]
Clobenztropine works by inhibiting the action of acetylcholine, a neurotransmitter that plays a key role in the transmission of nerve impulses in the brain. By blocking acetylcholine, clobenztropine helps to restore the balance between dopamine and acetylcholine, which is often disrupted in patients with Parkinson's disease and those experiencing EPS.
Side Effects[edit | edit source]
Common side effects of clobenztropine include dry mouth, blurred vision, constipation, and urinary retention. More serious side effects can include confusion, hallucinations, and tachycardia. Patients are advised to report any severe or persistent side effects to their healthcare provider.
Contraindications[edit | edit source]
Clobenztropine is contraindicated in individuals with narrow-angle glaucoma, myasthenia gravis, and obstructive gastrointestinal disorders. It should be used with caution in patients with a history of cardiovascular disease, prostatic hypertrophy, and renal impairment.
Dosage and Administration[edit | edit source]
The dosage of clobenztropine varies depending on the condition being treated and the patient's response to the medication. It is typically administered orally, and the dosage may be adjusted based on the patient's needs and tolerance.
History[edit | edit source]
Clobenztropine was developed as part of the search for effective treatments for Parkinson's disease and drug-induced movement disorders. It has been used in clinical practice for several decades and remains a valuable option in the management of these conditions.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD